RxDoctor Payments Data

Sarah Adams, MD

Family Medicine · Grove City, OHNPI 1346419371

Payments from drug & device makers

$3,119in general payments, 2019–2025

Across 179 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$389
  • Novo Nordisk$235
  • AstraZeneca$214
  • Pfizer$194
  • Lilly USA, LLC$175
  • GSK$172
  • plus $2K from 45 others

What the payments were for

  • Food & beverage$3,119100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,119 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$39,305
Medicare patients
139
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$106,447
OzempicSemaglutide73$88,157
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$77,561
LinzessLinaclotide75$52,229
MounjaroTirzepatide41$49,325
TrulicityDulaglutide39$48,159
JardianceEmpagliflozin53$46,515
XareltoRivaroxaban44$39,070
Humulin R U-500 KwikpenInsulin Regular, Human14$20,788
Breo ElliptaFluticasone/Vilanterol52$20,615
Tresiba Flextouch U-200Insulin Degludec16$17,174
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$13,168
Janumet XrSitagliptin Phos/Metformin Hcl16$13,000
JanuviaSitagliptin Phosphate15$11,952
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$9,047

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$172$107,222147 claims
PfizerEliquis$194$106,44786 claims
Lilly USA, LLCMounjaro, Trulicity$175$97,48480 claims
Novo NordiskOzempic$235$88,15773 claims
AbbVieLinzess$389$52,22975 claims
Boehringer IngelheimJardiance$74$46,51553 claims
Johnson & JohnsonXarelto$62$39,07044 claims
MerckJanumet Xr, Januvia$104$24,95231 claims
AstraZenecaSymbicort$214$8,77331 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Grove City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →